Compare Motilal Oswal Nifty MidSmall Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.12
1.86
NAV
₹10.37
₹37.51
Fund Started
29 Oct 2024
25 Jun 2018
Fund Size
₹29.42 Cr
₹6455.55 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
1 Year
-1.01%
-1.13%
3 Year
-
25.33%
5 Year
-
16.15%
Equity
99.84%
97.87%
Cash
0.16%
2.13%
Top 10 Holdings
Lupin Ltd. | 9.33% |
Fortis Healthcare Ltd. | 8.87% |
Laurus Labs Ltd. | 7.43% |
Aurobindo Pharma Ltd. | 6.36% |
Alkem Laboratories Ltd. | 5.94% |
Glenmark Pharmaceuticals Ltd. | 5.43% |
Mankind Pharma Ltd. | 4.72% |
Biocon Ltd. | 4.44% |
Ipca Laboratories Ltd. | 3.75% |
Krishna Institute of Medical Sciences Ltd | 3.13% |
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
Name
Swapnil P Mayekar
-
Start Date
18 Nov 2025
-
Description
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
29 Oct 2024
25 Jun 2018